Allurion Technologies Inc... (ALUR)
| Bid | 2.12 |
| Market Cap | 13.69M |
| Revenue (ttm) | 32.11M |
| Net Income (ttm) | -26.15M |
| EPS (ttm) | -10.82 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | -0.48 |
| Analyst | Buy |
| Ask | 2.38 |
| Volume | 30,560 |
| Avg. Volume (20D) | 1,584,667 |
| Open | 2.25 |
| Previous Close | 2.27 |
| Day's Range | 2.26 - 2.36 |
| 52-Week Range | 2.15 - 88.75 |
| Beta | -0.65 |
About ALUR
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite....
Analyst Forecast
According to 3 analyst ratings, the average rating for ALUR stock is "Buy." The 12-month stock price forecast is $16, which is an increase of 597.17% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · businesswire.com
Allurion Announces Postponement of Special Meeting of StockholdersNATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that its Special Meeting of Stockholders ...
4 weeks ago · seekingalpha.com
Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call TranscriptAllurion Technologies Inc. (NYSE:ALUR ) Q4 2024 Earnings Conference Call March 26, 2025 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Shantanu Gaur - Founder and Chief Executive ...
